Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 17.9.2026Ewopharma International, s.r.o. (EWO-SK-2)0870FISOPRINOSINE FORTE 1000 mg tablety (tbl 50x1000 mg (blis.PVC/PVDC/Al))1.10.2026U
 17.9.2026Ewopharma International, s.r.o. (EWO-SK-2)0869FISOPRINOSINE FORTE 1000 mg tablety (tbl 30x1000 mg (blis.PVC/PVDC/Al))1.10.2026U
 17.9.2026Viatris Healthcare Limited (VIM-1)41327Gopten 4 mg (cps 56x4 mg (blis.PVC/PVDC/Al))1.10.2026R
 17.9.2026Bayer AG (BAY)6623DXarelto 1 mg/ml granulát na perorálnu suspenziu (gru por 1x5,25 g/103,4 mg (fľ.skl.hnedá))21.9.2026R
 17.9.2026Cassella-med GmbH & Co. KG (CSM)8458COrocalm 1,5 mg/ml orálny roztokový sprej (aer ors 1x30 ml/176 vstrekov (fľ.HDPE s dáv.pumpou))17.9.2026R
 17.9.2026CHEPLAPHARM Registration GmbH (CEP-2)64308ZYPADHERA 405 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x405 mg (liek.inj.skl.) +1x3 ml solv.(liek.inj.skl.))16.10.2026R
 17.9.2026Pfizer Europe MA EEIG (PFI-BE-3)60387DALACIN T 1 % dermálna emulzia (emu der 1x30 ml (fľ.PE))21.9.2026O
 16.9.2026GALVEX, spol. s r.o. (GVX)5282AMagnesii lactas Galvex 500 mg (tbl 80x0,5 g (blis.PVC/PVDC/Al - povolený dopredaj do 30.9.2026))1.10.2026Z
 16.9.2026Farmak International Sp. z o.o. (FMZ-1)2355DDutasterid/Tamsulozín FMK (cps dur 90x0,5 mg/0,4 mg (fľ.HDPE))14.9.2026O
 16.9.2026Sanofi Winthrop Industrie (SWI-11)93821DISULONE 100 au protoxalate de fer (tbl 100)16.9.2026Z
 16.9.2026Baxter Holding B.V. (BAX-NL-1)53712Caelyx pegylated liposomal 2 mg/ml infúzny koncentrát (con inf 1x10 ml (liek.inj.skl.))11.9.2026R
 15.9.2026Baxter Slovakia s.r.o. (BAX-SK)0385BEndoxan 500 mg prášok na injekčný roztok (plv ino 6x500 mg (liek.inj.skl.))14.9.2026R
 15.9.2026G.L. Pharma GmbH (GLH-2)0666EPazopanib G.L. Pharma 400 mg filmom obalené tablety (tbl flm 30x400 mg (blis.Al/PVC/PE/PVDC))16.9.2026O
 15.9.2026G.L. Pharma GmbH (GLH-2)89806Oxypro 80 mg tablety s predĺženým uvoľňovaním (tbl plg 60x80 mg (blis.PVC/PVDC/Al))15.9.2026R
 14.9.2026Novartis Europharm Limited (NEH-IE)4579ESimulect 20 mg prášok na injekčný alebo infúzny roztok (plo jof 1x20 mg (liek.inj.skl.))14.9.2026R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)